176 related articles for article (PubMed ID: 38469149)
1. p300 KAT regulates SOX10 stability and function in human melanoma.
Waddell A; Grbic N; Leibowitz K; Wyant WA; Choudhury S; Park K; Collard M; Cole PA; Alani RM
bioRxiv; 2024 Feb; ():. PubMed ID: 38469149
[TBL] [Abstract][Full Text] [Related]
2. Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP.
Wang R; He Y; Robinson V; Yang Z; Hessler P; Lasko LM; Lu X; Bhathena A; Lai A; Uziel T; Lam LT
Mol Cancer Ther; 2018 Dec; 17(12):2543-2550. PubMed ID: 30266801
[TBL] [Abstract][Full Text] [Related]
3. MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma.
Kim E; Zucconi BE; Wu M; Nocco SE; Meyers DJ; McGee JS; Venkatesh S; Cohen DL; Gonzalez EC; Ryu B; Cole PA; Alani RM
Cancer Res; 2019 May; 79(10):2649-2661. PubMed ID: 30910803
[TBL] [Abstract][Full Text] [Related]
4. The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor.
Coe EA; Tan JY; Shapiro M; Louphrasitthiphol P; Bassett AR; Marques AC; Goding CR; Vance KW
PLoS Genet; 2019 Dec; 15(12):e1008501. PubMed ID: 31881017
[TBL] [Abstract][Full Text] [Related]
5. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.
Fufa TD; Baxter LL; Wedel JC; Gildea DE; ; Loftus SK; Pavan WJ
Epigenetics Chromatin; 2019 Aug; 12(1):50. PubMed ID: 31399133
[TBL] [Abstract][Full Text] [Related]
6. Curcumin Inhibits the Growth and Metastasis of Melanoma via miR-222-3p/SOX10/Notch Axis.
Tang Y; Cao Y
Dis Markers; 2022; 2022():3129781. PubMed ID: 35585935
[TBL] [Abstract][Full Text] [Related]
7. SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity.
Graf SA; Busch C; Bosserhoff AK; Besch R; Berking C
J Invest Dermatol; 2014 Aug; 134(8):2212-2220. PubMed ID: 24608986
[TBL] [Abstract][Full Text] [Related]
8. The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion.
Graf SA; Heppt MV; Wessely A; Krebs S; Kammerbauer C; Hornig E; Strieder A; Blum H; Bosserhoff AK; Berking C
Pigment Cell Melanoma Res; 2019 May; 32(3):424-434. PubMed ID: 30506895
[TBL] [Abstract][Full Text] [Related]
9. SOX10 Loss Sensitizes Melanoma Cells to Cytokine-Mediated Inflammatory Cell Death.
Rosenbaum SR; Caksa S; Stefanski CD; Trachtenberg IV; Wilson HP; Wilski NA; Ott CA; Purwin TJ; Haj JI; Pomante D; Kotas D; Chervoneva I; Capparelli C; Aplin AE
Mol Cancer Res; 2024 Feb; 22(2):209-220. PubMed ID: 37847239
[TBL] [Abstract][Full Text] [Related]
10. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS
J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825
[TBL] [Abstract][Full Text] [Related]
11. HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis.
Emmons MF; Bennett RL; Riva A; Gupta K; Carvalho LADC; Zhang C; Macaulay R; Dupéré-Richér D; Fang B; Seto E; Koomen JM; Li J; Chen YA; Forsyth PA; Licht JD; Smalley KSM
Nat Commun; 2023 Nov; 14(1):7759. PubMed ID: 38030596
[TBL] [Abstract][Full Text] [Related]
12. Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma.
Capparelli C; Purwin TJ; Glasheen M; Caksa S; Tiago M; Wilski N; Pomante D; Rosenbaum S; Nguyen MQ; Cai W; Franco-Barraza J; Zheng R; Kumar G; Chervoneva I; Shimada A; Rebecca VW; Snook AE; Hookim K; Xu X; Cukierman E; Herlyn M; Aplin AE
Nat Commun; 2022 Mar; 13(1):1381. PubMed ID: 35296667
[TBL] [Abstract][Full Text] [Related]
13. Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5.
Su Z; Zheng X; Zhang X; Wang Y; Zhu S; Lu F; Qu J; Hou L
J Dermatol Sci; 2017 Mar; 85(3):216-225. PubMed ID: 27955842
[TBL] [Abstract][Full Text] [Related]
14. Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears.
Clevenger J; Joseph C; Dawlett M; Guo M; Gong Y
Cancer Cytopathol; 2014 Oct; 122(10):779-85. PubMed ID: 24954720
[TBL] [Abstract][Full Text] [Related]
15. Sox10 controls migration of B16F10 melanoma cells through multiple regulatory target genes.
Seong I; Min HJ; Lee JH; Yeo CY; Kang DM; Oh ES; Hwang ES; Kim J
PLoS One; 2012; 7(2):e31477. PubMed ID: 22363655
[TBL] [Abstract][Full Text] [Related]
16. ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma.
Han S; Ren Y; He W; Liu H; Zhi Z; Zhu X; Yang T; Rong Y; Ma B; Purwin TJ; Ouyang Z; Li C; Wang X; Wang X; Yang H; Zheng Y; Aplin AE; Liu J; Shao Y
Nat Commun; 2018 Jan; 9(1):28. PubMed ID: 29295999
[TBL] [Abstract][Full Text] [Related]
17.
Ennen M; Keime C; Gambi G; Kieny A; Coassolo S; Thibault-Carpentier C; Margerin-Schaller F; Davidson G; Vagne C; Lipsker D; Davidson I
Clin Cancer Res; 2017 Nov; 23(22):7097-7107. PubMed ID: 28855355
[No Abstract] [Full Text] [Related]
18. SOX9 is a dose-dependent metastatic fate determinant in melanoma.
Yang X; Liang R; Liu C; Liu JA; Cheung MPL; Liu X; Man OY; Guan XY; Lung HL; Cheung M
J Exp Clin Cancer Res; 2019 Jan; 38(1):17. PubMed ID: 30642390
[TBL] [Abstract][Full Text] [Related]
19. SOX5 is involved in balanced MITF regulation in human melanoma cells.
Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R
BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636
[TBL] [Abstract][Full Text] [Related]
20. SOX10 expression in superficial spreading and nodular malignant melanomas.
Agnarsdóttir M; Sooman L; Bolander A; Strömberg S; Rexhepaj E; Bergqvist M; Ponten F; Gallagher W; Lennartsson J; Ekman S; Uhlen M; Hedstrand H
Melanoma Res; 2010 Dec; 20(6):468-78. PubMed ID: 20890226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]